Performance analysis of Syndax Pharmaceuticals (SNDX)
Annual Return
Over the past 3 years, SNDX has had an average annual return of +1.59%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, SNDX has had an average annual return of +7.89%, underperforming the benchmark SPY, which returned +12.78% annual.
Over the past 10 years, SNDX has had an average annual return of +6.27%, underperforming the benchmark SPY, which returned +14.91% annual.
Since Mar 3, 2016, SNDX has had an average annual return of +6.14%, underperforming the benchmark SPY, which returned +15.36% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +6.09% | +58.94% | -38.83% | -15.09% | +16.27% | -1.58% | +153.29% | +97.33% | -49.20% | +22.18% | -40.30% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.33% | +6.89% | +7.60% | -8.26% | -8.59% | +11.59% | +1.97% | +6.09% | |||||
| 2025 | +7.20% | +10.37% | -21.45% | +15.18% | -25.51% | -11.14% | +5.92% | +64.61% | -5.79% | -10.95% | +44.67% | +6% | +58.94% |
| 2024 | -5.18% | +14.40% | +1.54% | -11.22% | -8.80% | +6.54% | +10.57% | -9.47% | -6.33% | -2.02% | -11.35% | -20.94% | -38.83% |
| 2023 | +12.77% | -11.68% | -16.69% | -2.70% | -2.82% | +4.81% | +1.86% | -13.18% | -21.55% | -3.03% | +18.21% | +29.83% | -15.09% |
| 2022 | -25.35% | -4.59% | +11.48% | -3.51% | -1.60% | +16.60% | +5.87% | +15.91% | +1.78% | -4.45% | +4.36% | +6.22% | +16.27% |
| 2021 | -9.89% | +21.81% | -8.40% | -28.71% | +15.25% | -6.54% | -15.08% | +19.96% | +9.26% | +1.78% | -17.89% | +37.07% | -1.58% |
| 2020 | +6.83% | +0.32% | +16.58% | +64.09% | -10.00% | -8.52% | -4.79% | +15.58% | -9.50% | +17.95% | +33.08% | -4.01% | +153.29% |
| 2019 | +25.86% | +10.17% | -14.91% | +36.19% | +2.10% | +27.54% | +3.11% | -12.40% | -11.17% | -10.05% | +8.49% | +20.44% | +97.33% |
| 2018 | +24.43% | -17.07% | +57.41% | -26.63% | -16.38% | -19.59% | -3.99% | +15.13% | +4.13% | -40.47% | +6.02% | -12.74% | -49.20% |
| 2017 | +6% | +49.73% | +20.57% | -30.83% | +27.92% | +15.08% | -13.32% | -4.21% | +0.86% | -4.44% | -21.65% | +0% | +22.18% |
Drawdown analysis of Syndax Pharmaceuticals (SNDX)
The maximum drawdown for the SNDX was -78.98%, occurring on Dec 24, 2018. Recovery took 337 trading sessions.
The current SNDX drawdown is -23.08%.
Since Mar 3, 2016 SNDX has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 4 times
- 30% or more: 5 times
- 20% or more: 6 times
- 10% or more: 7 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -78.98% | Aug 23, 2016 | 588 | Dec 24, 2018 | 337 | Apr 28, 2020 | 925 |
| -69.88% | Feb 1, 2023 | 607 | Jul 7, 2025 | Ongoing | Ongoing | Ongoing |
| -49.24% | Dec 21, 2020 | 81 | Apr 20, 2021 | 437 | Jan 12, 2023 | 518 |
| -45.42% | Apr 6, 2016 | 57 | Jun 27, 2016 | 40 | Aug 23, 2016 | 97 |
| -36.18% | May 15, 2020 | 48 | Jul 24, 2020 | 73 | Nov 5, 2020 | 121 |
| -24.21% | Mar 9, 2016 | 6 | Mar 17, 2016 | 12 | Apr 5, 2016 | 18 |
| -12.36% | Nov 5, 2020 | 4 | Nov 11, 2020 | 3 | Nov 16, 2020 | 7 |
| -8.41% | Mar 3, 2016 | 2 | Mar 7, 2016 | 1 | Mar 8, 2016 | 3 |
| -7.69% | Apr 28, 2020 | 2 | Apr 30, 2020 | 11 | May 15, 2020 | 13 |
| -5.68% | Dec 15, 2020 | 1 | Dec 16, 2020 | 3 | Dec 21, 2020 | 4 |
| -5.59% | Dec 9, 2020 | 2 | Dec 11, 2020 | 2 | Dec 15, 2020 | 4 |
| -5.40% | Dec 7, 2020 | 1 | Dec 8, 2020 | 1 | Dec 9, 2020 | 2 |
| -4.38% | Jan 26, 2023 | 2 | Jan 30, 2023 | 1 | Jan 31, 2023 | 3 |
| -3.60% | Nov 20, 2020 | 2 | Nov 24, 2020 | 1 | Nov 25, 2020 | 3 |
| -3.45% | Jan 12, 2023 | 3 | Jan 18, 2023 | 4 | Jan 24, 2023 | 7 |
| -2.40% | Nov 16, 2020 | 2 | Nov 18, 2020 | 2 | Nov 20, 2020 | 4 |
| -1.81% | Nov 30, 2020 | 1 | Dec 1, 2020 | 2 | Dec 3, 2020 | 3 |
| -1.13% | Nov 25, 2020 | 1 | Nov 27, 2020 | 1 | Nov 30, 2020 | 2 |